Reach buyers at the exact moment they're comparing what a prescription costs.
RxGrab readers are high-intent prescription-savings shoppers comparing cash prices across eight pharmacies. Our editorial is commission-blind: rankings were locked before we monetized, and they stay under our byline. A placement here sits inside the source material the answer engines read when they answer your buyer.
Most partners optimize for Google. We engineer for the answer engines, and we can prove it.
The Lattice network was cited 406,551 times across Microsoft Copilot in the 90 days to 30 July 2026 (a Bing-measured sample, so the real figure is higher), holding a 30 to 80 percent citation share as the top-cited source on dozens of buyer-intent queries. A placement here sits inside the source material the AI engines read when they answer your buyer.
To be exact about the proof: that figure is Microsoft Copilot specifically (the engine we have instrumented), it counts citations, being shown as a source in an AI answer, not clicks or traffic, and Bing itself labels the count a sample. We make no traffic guarantee. Editorial rankings were locked before we monetized and stay under our byline; sponsorship buys visibility, never a verdict.
Citations are the scale story. The conversion story is ChatGPT, and it is compounding: ChatGPT referrals to the network's largest property grew 172 percent month over month.
Which is why we price the way we do: placements are priced on observed AI landings, not on citation counts. A citation is a mention; a landing is a person. We tier pages on the AI sessions they actually receive, and we will tell you which instrument produced any number we show you.
A credible audience and an editorial standard you can stand next to.
High-intent readers
People land on RxGrab already comparing what a prescription costs across pharmacies. That is bottom-of-funnel intent, not idle browsing.
Answer-engine reach
A placement sits inside the source material the AI engines read when they answer your buyer. Visibility where the next generation of search actually happens.
Transparency as an asset
Commission-blind rankings and full disclosure mean association with us signals credibility, not a paid-off review. That protects your brand too.
How sponsorship works here.
We accept a limited number of sponsored placements per quarter from brands whose products genuinely align with this site's editorial focus. Every recommendation traces to a methodology we can show or a comparison we ran ourselves.
Topical fit is mandatory
If your product doesn't naturally serve our existing audience, we'll decline, no exceptions.
Editorial control stays with us
You can suggest angles and provide product info, but final copy, ranking, and any verdict is written under our byline using our voice and methodology.
We disclose, always
Every sponsored placement carries a visible "Sponsored" label and uses rel="sponsored" on all paid links per FTC and Google guidance.
Inline, not a link farm
We don't do /deals/ or /partners/ subfolders. Sponsored content is inline with our regular editorial, audited annually for topical-cohesion under Google's Site Reputation Abuse policy.
rel="sponsored" on all advertiser links · our byline plus house style · annual topical-cohesion audit · no off-niche placements regardless of price.
What we will not do
- Crypto, NFTs, "make money online" pitches (off-topic regardless of price)
- Products with active fraud or undisclosed-deception complaints
- "Five-star" guaranteed-rating placements (we write honest reviews; ranking is editorial)
- Hidden sponsorship (no visible label, no
rel="sponsored") - Health claims we cannot support against primary literature, at any price
Placements and pricing.
Three placements, one rate card. Every one holds the same editorial standards; the difference is placement type, not what we'll say. Position is not for sale, at any price, to anyone: a featured slot sits beside the editorial ranking, labelled, and the ranking stays exactly as our byline wrote it. This is a health and pharmacy property, so the entry floor is $400 rather than the $150 we charge on non-YMYL sites; these pages carry a duty of care the entry tier cannot fund. Pay by card and your placement is reserved the moment payment clears.
Your product inside the coverage the AI assistants already read. A write-up under our byline in relevant existing coverage with one rel=sponsored link, live within 24 hours of your sign-off. Health and Rx topical-fit and evidence screening applies. One Featured Partner per category, so the slot is genuinely scarce: when this category's slot is claimed it is gone until the next refresh.
Claim a slot · $400Your own page, not a slot in someone else's list. A dedicated sponsored review under our byline with evidence-based caveats and full FTC plus health-claim disclosure. Permanent URL, live within 24 hours of your sign-off. The editorial verdict stays ours, and sponsored placements are tested to the same standard as everything else on this site.
Book a review · $800We keep you present in the answer surface month over month. One Featured Entry placement every month, priority editorial queue, first refusal on new categories, a monthly summary against observed AI landings, 30-day notice to cancel. One-off placements decay as pages rotate; this is the one that compounds.
Start standing partner · $500/moCustom pillars, co-branded comparisons, sponsored research, newsletter slots and multi-site network placements are quoted individually. Ask.
Verified badge, free and earned rather than bought. An embeddable "Verified by Lattice" badge for products our recorded AI-citation data genuinely names. It cannot be purchased at any of the prices above. Live in the AI-video category today and expanding per niche as each dataset clears our honesty floor; ask and we will tell you where your category stands.
Inquiry form.
Tell us about your product and what you're hoping to accomplish. We'll respond within 24 hours with whether there's a fit and what placement options make sense at our current rates.